explore -WSS

explore

author：entertainment 2025-10-01 18:44:54 - browse：13164

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： ASCO Takeaways: Winners, snoozers, and the art of cancer care

WSS

Congress needs to close a vaccine

Superbugs, antibiotic resistance get scrutiny in congress

Finland to offer bird flu vaccine to select groups of people, a possible global first

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Companies helping big Covid

Antibody drugs appear effective. Now can we make enough of them?

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Activists slam private health insurers over coverage restrictions

China sends large group of warplanes, navy ships towards Taiwan in forceful display

The cancer drug shortage isn’t new — and neither are the solutions

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Medical records are filled with copy

A new initiative will help leaders fight the next pandemic

The high cost of giving birth even with insurance

Superbugs, antibiotic resistance get scrutiny in congress

The high cost of giving birth even with insurance

One Duchenne patient's bittersweet hope for new treatment

Wikipedia

Blinken talks high

Companies helping big Covid

STAT wants to know your pick for a great summer read or listen

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Antibody drugs appear effective. Now can we make enough of them?

Grail's uphill battle for Medicare to cover its cancer screening test

explore

Wikipedia

focus

focus